811 / 1609
Jones HA et al J Clin Oncol 2009;27:4939-47
<50 años
>=50 años
Age and dose
11.4%
5.3%
Current study
close + margins
boost HDR
3.2%
11.9%
Positive
margin
13.1%
4.6%
≤ 50 years old
> 50 years old
COMPARISON WITH BOOST TRIAL